San Diego-primarily based Viking Therapeutics marked by itself as a serious competitor while in the weight loss drug current market in February following revealing promising details from the mid-stage trial of experimental drug VK2735, which recommended it rivaled—and outperformed—Novo and Lilly drugs when supplied for a weekly injection As wel